Onconetix, Inc.
Data quality: 100%
ONCO
Nasdaq
Manufacturing
Chemicals
$1.22
▲
$0.09
(7.96%)
Mkt Cap: 874,555.0
Price
$1.22
Mkt Cap
874,555.0
Day Range
$1.14 — $2.82
52-Week Range
$1.10 — $74.38
Volume
234,685,536
Open $1.62
50D / 200D Avg
$4.14
70.51% below
50D / 200D Avg
$12.28
90.06% below
Quick Summary
Key Takeaways
Negative free cash flow of -9.71 M
Capital efficient — spends only 3.49% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-67.70%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-302.29%
Below sector avg (-51.02%)
ROIC-287.82%
Net Margin-1720.98%
Op. Margin-2190.03%
Safety
Debt / Equity
N/A
Current Ratio0.08
Interest Coverage-23.78
Valuation
PE (TTM)
-0.06
Above sector avg (-1.98)
P/B Ratio0.26
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.1 | -2.0 |
| P/B | 0.3 | 5.1 |
| ROE % | -302.3 | -51.0 |
| Net Margin % | -1721.0 | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -67.70% | Revenue Growth (3Y) | 273.45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 815,371.0 | Net Income (TTM) | -14.03 M |
| ROE | -302.29% | ROA | -72.34% |
| Gross Margin | 77.62% | Operating Margin | -2190.03% |
| Net Margin | -1720.98% | Free Cash Flow (TTM) | -9.71 M |
| ROIC | -287.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.08 |
| Interest Coverage | -23.78 | Asset Turnover | 0.04 |
| Working Capital | -15.00 M | Tangible Book Value | -14.81 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.06 | Forward P/E | N/A |
| P/B Ratio | 0.26 | P/S Ratio | 1.07 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -1109.92% | ||
| Market Cap | 874,555.0 | Enterprise Value | 874,555.0 |
| Per Share | |||
| EPS (Diluted TTM) | -16.56 | Revenue / Share | 1.14 |
| FCF / Share | -13.54 | OCF / Share | -13.50 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 3.49% | FCF Conversion | 69.17% |
| SBC-Adj. FCF | -9.82 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 815,371.0 | 2.52 M | 58,465.0 | — |
| Net Income | -14.03 M | -58.69 M | -37.41 M | -13.42 M |
| EPS (Diluted) | -16.56 | -21.45 | -2.19 | -1.10 |
| Gross Profit | 632,913.0 | 1.06 M | -1.13 M | — |
| Operating Income | -17.86 M | -56.49 M | -36.03 M | -13.48 M |
| EBITDA | — | — | — | — |
| R&D Expenses | — | 154,359.0 | 1.95 M | 4.13 M |
| SG&A Expenses | 7.04 M | 11.23 M | 14.77 M | — |
| D&A | 15,170.0 | 731,345.0 | 43,937.0 | — |
| Interest Expense | 751,005.0 | 873,433.0 | 671,625.0 | — |
| Income Tax | 525.0 | -1.05 M | -12,593.0 | 3.16 T |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 24.93 M | 28.18 M | 87.52 M | 26.31 M |
| Total Liabilities | 9.16 M | 18.57 M | 21.88 M | 3.92 M |
| Shareholders' Equity | 15.76 M | 8.54 M | -5.60 M | 22.39 M |
| Total Debt | — | — | — | — |
| Cash & Equivalents | — | — | — | 25.75 M |
| Current Assets | 6.07 M | 950,267.0 | 5.84 M | 26.26 M |
| Current Liabilities | 9.14 M | 18.29 M | 17.19 M | 3.92 M |
{"event":"ticker_viewed","properties":{"ticker":"ONCO","listing_kind":"stock","pathname":"/stocks/onco","exchange":"Nasdaq","country":"US"}}